Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study.

Thomaidis L, Bertou G, Critselis E, Spoulou V, Kafetzis DA, Theodoridou M.

BMC Pediatr. 2010 Dec 27;10:99. doi: 10.1186/1471-2431-10-99.

2.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
3.

[Link between depression and academic self-esteem in gifted children].

Bénony H, Van Der Elst D, Chahraoui K, Bénony C, Marnier JP.

Encephale. 2007 Jan-Feb;33(1):11-20. French.

PMID:
17457290
4.

Poor health-related quality of life and abnormal psychosocial adjustment in Italian children with perinatal HIV infection receiving highly active antiretroviral treatment.

Bomba M, Nacinovich R, Oggiano S, Cassani M, Baushi L, Bertulli C, Longhi D, Coppini S, Parrinello G, Plebani A, Badolato R.

AIDS Care. 2010 Jul;22(7):858-65. doi: 10.1080/09540120903483018.

PMID:
20635250
5.

A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.

Alimenti A, Forbes JC, Oberlander TF, Money DM, Grunau RE, Papsdorf MP, Maan E, Cole LJ, Burdge DR.

Pediatrics. 2006 Oct;118(4):e1139-45. Epub 2006 Aug 28.

PMID:
16940166
6.

Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART).

Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L.

Dev Neuropsychol. 2006;30(2):633-57.

PMID:
16995830
7.

[Neurologic aspects of HIV infections--follow-up of pediatric patients].

Kollár K, Jelenik Z, Hegelsberger E.

Ideggyogy Sz. 2003 Nov 20;56(11-12):397-404. Hungarian. Erratum in: Ideggyogy Sz. 2004 Jan 20;57(1-2):54.

PMID:
14743594
8.

Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy.

Lindsey JC, Malee KM, Brouwers P, Hughes MD; PACTG 219C Study Team.

Pediatrics. 2007 Mar;119(3):e681-93. Epub 2007 Feb 12.

PMID:
17296781
9.

Effects of perinatal HIV infection and associated risk factors on cognitive development among young children.

Smith R, Malee K, Leighty R, Brouwers P, Mellins C, Hittelman J, Chase C, Blasini I; Women and Infants Transmission Study Group.

Pediatrics. 2006 Mar;117(3):851-62.

PMID:
16510667
10.

Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.

Lorenzo J, Barton B, Arnold SS, North KN.

J Pediatr. 2013 Nov;163(5):1479-83.e1. doi: 10.1016/j.jpeds.2013.06.038. Epub 2013 Aug 1.

PMID:
23910685
11.

Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.

Storm DS, Boland MG, Gortmaker SL, He Y, Skurnick J, Howland L, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Study Team.

Pediatrics. 2005 Feb;115(2):e173-82. Epub 2005 Jan 3.

PMID:
15629958
12.

Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa.

Lowick S, Sawry S, Meyers T.

Psychol Health Med. 2012;17(5):599-610. doi: 10.1080/13548506.2011.648201. Epub 2012 Feb 7.

PMID:
22313239
13.

Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease.

Tamula MA, Wolters PL, Walsek C, Zeichner S, Civitello L.

Pediatrics. 2003 Sep;112(3 Pt 1):679-84.

PMID:
12949303
14.

A behavioral and cognitive profile of clinically stable HIV-infected children.

Nozyce ML, Lee SS, Wiznia A, Nachman S, Mofenson LM, Smith ME, Yogev R, McIntosh K, Stanley K, Pelton S.

Pediatrics. 2006 Mar;117(3):763-70.

PMID:
16510656
15.

The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.

Jevtović Dj, Vanovac V, Veselinović M, Salemović D, Ranin J, Stefanova E.

Biomed Pharmacother. 2009 Sep;63(8):561-5. doi: 10.1016/j.biopha.2008.09.015. Epub 2008 Nov 5.

PMID:
19026516
16.

International collaborative study of intracytoplasmic sperm injection-conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: cognitive and motor assessments.

Ponjaert-Kristoffersen I, Bonduelle M, Barnes J, Nekkebroeck J, Loft A, Wennerholm UB, Tarlatzis BC, Peters C, Hagberg BS, Berner A, Sutcliffe AG.

Pediatrics. 2005 Mar;115(3):e283-9.

PMID:
15741353
17.

Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia.

Biadgilign S, Deribew A, Amberbir A, Deribe K.

BMC Pediatr. 2008 Dec 6;8:53. doi: 10.1186/1471-2431-8-53.

18.

Neurocognitive function profile in HIV-infected school-age children.

Koekkoek S, de Sonneville LM, Wolfs TF, Licht R, Geelen SP.

Eur J Paediatr Neurol. 2008 Jul;12(4):290-7. Epub 2007 Oct 18.

PMID:
17950012
19.

Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.

Roizen N, Kasza K, Karrison T, Mets M, Noble AG, Boyer K, Swisher C, Meier P, Remington J, Jalbrzikowski J, McLeod R, Kipp M, Rabiah P, Chamot D, Estes R, Cezar S, Mack D, Pfiffner L, Stein M, Danis B, Patel D, Hopkins J, Holfels E, Stein L, Withers S, Cameron A, Perkins J, Heydemann P.

Pediatrics. 2006 Aug;118(2):e379-90. Epub 2006 Jul 24.

PMID:
16864640
20.

Coronary artery calcium in HIV-infected men treated with highly active antiretroviral therapy.

Robinson FP, Hoff JA, Kondos GT.

J Cardiovasc Nurs. 2005 May-Jun;20(3):149-54.

PMID:
15870584
Items per page

Supplemental Content

Write to the Help Desk